The PARP inhibitor, ABT-888 potentiates temozolomide: correlation with drug levels and reduction in PARP activity in vivo.
Year: 2008
Type: article
Source: PubMed
Authors: Joann P Palma, Luis E Rodriguez, Velitchka D Bontcheva-Diaz, Jennifer J Bouska, Gail Bukofzer, Milagros Colon-Lopez, Ran Guan, Kenneth Jarvis, Eric F Johnson, Vered Klinghofer, Xuesong Liu, Amanda Olson, Mary J Saltarelli, Yan Shi, Jason A Stavropoulos, Gui-Dong Zhu, Thomas D Penning, Yan Luo, Vincent L Giranda, Saul H Rosenberg, David J Frost, Cherrie K Donawho
Institution: Abbott (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2183964012
